Research News
National prostate cancer trial testing therapy based on Cleveland Clinic molecular discovery
The clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer, HSD3B1, and is in clinical trials at nine sites across the U.S.
Cleveland Clinic selected for participation in National Chemical Biology Consortium
The center will work alongside other top research institutions on therapeutics projects.
Research into how cells “self-destruct” maps out body’s defenses against viruses
Cleveland Clinic research into anti-viral immunity identified a novel mechanism in necroptosis, a form of programmed cell death